NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors

Active Not RecruitingN/A

Sponsor: M.D. Anderson Cancer Center

Conditions: COVID-19 Infection, Malignant Solid Neoplasm

Interventions: Quality-of-Life Assessment, Questionnaire Administration, Survey Administration

Countries: United States

This study uses questionnaires to gain an understanding of how experiences during the COVID-19 pandemic, regardless of COVID-19 status, may have impacted health-related quality of life (HRQOL) and other areas such as COVID-19-specific psychological distress, disruptions to health care, finances and social interactions in cancer patients. The coronavirus disease 2019 (COVID-19) is an infectious disease that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The information learned from this study will guide the development of psychosocial programs to improve patient care and outcomes in cancer patients and survivors in the context of facing a global pandemic.

Eligibility overview

Sex: ALL

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Prior patients who participated in one of the following protocols: 2012-0112, 2009-0976, or 2005-0035
* Has an active email address or can be contacted via MyChart or personal email

Exclusion Criteria:

* No evidence of consent from prior clinical trials

Locations (1)

Houston, Texas, United States